SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001703057-24-000021
Filing Date
2024-02-20
Accepted
2024-02-20 16:49:36
Documents
8
Effectiveness Date
2024-02-20
Reference 429
333-269896

Document Format Files

Seq Description Document Type Size
1 S-8 abcellera-formsx82024draft.htm S-8 90615
2 EX-FILING FEES feetable-exhibit107.htm EX-FILING FEES 2775
3 EX-5.1 abcellera-ex51opinionsx8.htm EX-5.1 5463
4 EX-23.1 abclconsent-formsx82023k.htm EX-23.1 1451
5 abcellera-ex51opinionsx8001.jpg GRAPHIC 198804
6 abcellera-ex51opinionsx8002.jpg GRAPHIC 153260
7 abclconsent-formsx82023k001.jpg GRAPHIC 75006
8 feetable-exhibit107001.jpg GRAPHIC 155067
  Complete submission text file 0001703057-24-000021.txt   903465
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277192 | Film No.: 24654363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)